412 related articles for article (PubMed ID: 33921862)
1. Protection of Residual Renal Function and Nutritional Treatment: First Step Strategy for Reduction of Uremic Toxins in End-Stage Kidney Disease Patients.
Cupisti A; Bolasco P; D'Alessandro C; Giannese D; Sabatino A; Fiaccadori E
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33921862
[TBL] [Abstract][Full Text] [Related]
2. Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.
van Gelder MK; Middel IR; Vernooij RWM; Bots ML; Verhaar MC; Masereeuw R; Grooteman MP; Nubé MJ; van den Dorpel MA; Blankestijn PJ; Rookmaaker MB; Gerritsen KGF
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272776
[TBL] [Abstract][Full Text] [Related]
3. Optical Method and Biochemical Source for the Assessment of the Middle-Molecule Uremic Toxin β2-Microglobulin in Spent Dialysate.
Paats J; Adoberg A; Arund J; Fridolin I; Lauri K; Leis L; Luman M; Tanner R
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807387
[TBL] [Abstract][Full Text] [Related]
4. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
5. A Novel Uremic Score Reflecting Accumulation of Specific Uremic Toxins More Precisely Predicts One-Year Mortality after Hemodialysis Commencement: A Retrospective Cohort Study.
Arai Y; Shioji S; Tanaka H; Katagiri D; Hinoshita F
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33019590
[TBL] [Abstract][Full Text] [Related]
6. Residual renal function: a paradigm shift.
Lowenstein J; Grantham JJ
Kidney Int; 2017 Mar; 91(3):561-565. PubMed ID: 28202171
[TBL] [Abstract][Full Text] [Related]
7. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
[TBL] [Abstract][Full Text] [Related]
8. Uremic Toxins and Blood Purification: A Review of Current Evidence and Future Perspectives.
Magnani S; Atti M
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33808345
[TBL] [Abstract][Full Text] [Related]
9. Composite Uremic Load and Physical Performance in Hemodialysis Patients: A Cross-Sectional Study.
Vanden Wyngaert K; Van Craenenbroeck AH; Holvoet E; Calders P; Van Biesen W; Eloot S
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32098304
[TBL] [Abstract][Full Text] [Related]
10. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632
[TBL] [Abstract][Full Text] [Related]
11. Once-weekly hemodialysis combined with low-protein and low-salt dietary treatment as a favorable therapeutic modality for selected patients with end-stage renal failure: a prospective observational study in Japanese patients.
Nakao T; Kanazawa Y; Takahashi T
BMC Nephrol; 2018 Jun; 19(1):151. PubMed ID: 29954331
[TBL] [Abstract][Full Text] [Related]
12. Food-Derived Uremic Toxins in Chronic Kidney Disease.
Lauriola M; Farré R; Evenepoel P; Overbeek SA; Meijers B
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828430
[TBL] [Abstract][Full Text] [Related]
13. A rapid and sensitive method for simultaneous determination of eight protein-bound uremic toxins in human serum by UHPLC-MS/MS: application in assessing peritoneal dialysis.
Wang Z; Jiang H; Chen X; Song X; Xu F; Chen F; Mao Z; Gao S; Chen W
J Pharm Biomed Anal; 2020 Jul; 186():113312. PubMed ID: 32361090
[TBL] [Abstract][Full Text] [Related]
14. Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis.
Reis T; Hutchison C; de Assis Rocha Neves F; Zawadzki B; Zanella M; Ronco C; Rosner MH
Blood Purif; 2023; 52(3):242-254. PubMed ID: 36657410
[TBL] [Abstract][Full Text] [Related]
15. Future Avenues to Decrease Uremic Toxin Concentration.
Vanholder RC; Eloot S; Glorieux GL
Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
[TBL] [Abstract][Full Text] [Related]
16. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease.
Moradi H; Sica DA; Kalantar-Zadeh K
Am J Nephrol; 2013; 38(2):136-48. PubMed ID: 23941724
[TBL] [Abstract][Full Text] [Related]
18. A bench to bedside view of uremic toxins.
Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and chemokines systemic levels are related to dialysis adequacy and creatinine clearance in patients with end-stage renal disease undergoing hemodialysis.
Silva RE; Santos EC; Justino PBI; Santos MP; Galdino G; Gonçalves RV; Novaes RD
Int Immunopharmacol; 2021 Nov; 100():108154. PubMed ID: 34555645
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
